Audio Clinical Professionals

AQP4 Antibody Testing in Neuromyelitis Optica Spectrum Disorder

Reviews AQP4 Antibody Testing in Neuromyelitis Optica Spectrum Disorder and highlights the practical decisions that shape diagnosis, treatment, and follow-up.

This resource is private and requires a subscriber login to stream. SIGN IN to continue.

Duration

00:03:20

File size

0.76 MB

Practitioner-Guided Note

Use AQP4 Antibody Testing in Neuromyelitis Optica Spectrum Disorder to guide the working diagnosis and next step; let the main risk or management issue drive escalation, treatment choice, and follow-up.

Key Takeaways

Testing should always be performed directly on blood serum, which has proven to be significantly more sensitive than testing the cerebrospinal fluid.; This means that while a negative result cannot completely exclude the condition, a positive antibody test provides ironclad support for the diagnosis.; Highly targeted aquaporin-four cell-based assay yields a sensitivity of about 70%, but its specificity is nearly 100%.; Highly suspect neuromyelitis optica if the individual is of African American, Hispanic, or Asian descent.; Because the antibody can occasionally read as false-negative early on, it is highly prudent to repeat the blood test if your clinical suspicion remains strong.